Old Web
English
Sign In
Acemap
>
Paper
>
MA26.11 Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
MA26.11 Effects of Dose Modifications on the Safety and Efficacy of Dacomitinib for EGFR Mutation-Positive NSCLC
2018
T. Mok
K. Nakagawa
Rafael Rosell
K.H. Lee
J. Corral
Maria Rita Migliorino
Adam Pluzanski
R. Linke
G. Devgan
Eric Sbar
S. Quinn
T. Wang
Y. Wu
Keywords:
General surgery
Cancer research
Dacomitinib
Medicine
Mutation
Oncology
Pathology
egfr mutation
Internal medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]